QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row
2023年7月26日 - 5:00AM
ビジネスワイヤ(英語)
Company receives top customer rating in the
2023 IMV ServiceTrak™ Awards
QuidelOrtho Corporation (Nasdaq: QDEL) (“QuidelOrtho”), a
global provider of innovative in vitro diagnostics technologies
designed for point-of-care settings, clinical labs and transfusion
medicine, announced today that it has earned the No. 1 ranking in
the diagnostics industry for Overall Customer Satisfaction in the
2023 IMV ServiceTrak Awards for the sixth consecutive year. The
ranking is based on interviews conducted with laboratory
professionals, including QuidelOrtho’s customers, from more than
1,200 clinical testing locations operating over 1,900 collective
instruments. The prestigious annual IMV ServiceTrak Awards rankings
affirm the continued power and impact of QuidelOrtho’s innovative
services and informatics platform.
In addition to its No. 1 ranking in Overall Customer
Satisfaction, QuidelOrtho achieved top rankings in the following
categories:
- #1 in Net Promotor Score (NPS) for the eighth consecutive
year
- #1 in Integrated Systems in:
- Customer satisfaction
- System performance
- Overall service performance
- #1 in Clinical Chemistry in:
- Customer satisfaction
- System performance
- Overall service performance
“For six straight years, our customers have rated QuidelOrtho #1
for overall customer satisfaction in the U.S. diagnostics market
based on real-world system and service performance under some of
the most challenging conditions in modern history,” said Douglas
Bryant, President and Chief Executive Officer of QuidelOrtho. “This
honor reflects both our attention to engineering obstacles out of
the laboratory and our culture of intense customer focus, which
combine to maximize efficiencies, improve patient care and create
the kind of deep and enduring customer partnerships that have
yielded industry-best Net Promoter Scores for eight consecutive
years.”
QuidelOrtho’s services and informatics program is the evolution
of how service, expertise, technology and data-driven solutions
come together to create a more effective, efficient lab, so labs
can focus on improving patient outcomes. Superior partnership and
support are more important than ever as labs experience greater
demand for more complex testing, challenging budgets and a
workforce shifting from more specialists to more generalists. With
QuidelOrtho solutions, labs get the partnership they need, along
with next-level data services to continually improve the speed and
quality of care.
“It’s the people who deliver the award-winning partnership and
support that labs depend on,” said Karen Taylor, vice president of
QuidelOrtho’s global customer experience and services organization.
“I’m proud of our teams and their extraordinary ability to focus on
and deliver what’s important to customers now and into the
future.”
For more information about QuidelOrtho’s award-winning services
and informatics program, visit the QuidelOrtho services and
informatics home page on QuidelOrtho’s U.S. website.
About QuidelOrtho Corporation
QuidelOrtho Corporation (Nasdaq: QDEL) is a world leader in in
vitro diagnostics, developing and manufacturing intelligent
solutions that transform data into understanding and action for
more people in more places every day.
Offering industry-leading expertise in immunoassay and molecular
testing, clinical chemistry and transfusion medicine, bringing
fast, accurate and reliable diagnostics when and where they are
needed – from home to hospital, lab to clinic. So that patients,
clinicians and health officials can spot trends sooner, respond
quicker and chart the course ahead with accuracy and
confidence.
Building upon its 80-year legacy of groundbreaking innovation,
QuidelOrtho continues to partner with customers across the
healthcare continuum and around the globe to forge a new diagnostic
frontier. One where insights and solutions know no bounds,
expertise seamlessly connects and a more informed path is
illuminated for each of us.
QuidelOrtho is transforming the power of diagnostics into a
healthier future for all.
For more information, please visit www.quidelortho.com. Source:
QuidelOrtho Corporation
About IMV
IMV is part of the Science and Medicine Group, the leading
market research and business intelligence provider to the
laboratory diagnostic industry. Each year, IMV produces a series of
proprietary ServiceTrak Clinical reports derived from extensive
phone surveys with clinical laboratory professionals to determine
their level of satisfaction with the service they receive for their
clinical diagnostic equipment and with the equipment manufacturers.
For more information, visit www.imvinfo.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230725514499/en/
Media: media@quidelortho.com
QuidelOrtho (NASDAQ:QDEL)
過去 株価チャート
から 4 2024 まで 5 2024
QuidelOrtho (NASDAQ:QDEL)
過去 株価チャート
から 5 2023 まで 5 2024